AI Research
Reports
Institutional-grade monthly research in 8 structured parts — from macro context to individual stock conviction scores. Powered by AI, grounded in NSE/BSE data.
Educational content only. Rare Sense is not registered with SEBI as an Investment Adviser or Research Analyst. Nothing in this report constitutes investment advice, a buy/sell recommendation, or a solicitation. All analysis is AI-generated for informational purposes. Consult a SEBI-registered adviser before making any investment decision.
The RBI's 25 bps rate cut in February 2026 to 5.75% is feeding through to credit growth, though the MPC remains data-dependent with core inflation hovering at 4.2%. FII outflows have persisted into April amid global risk-off sentiment driven by renewed US tariff concerns, but robust DII inflows of ₹12,350 Cr MTD continue to provide a domestic floor. Sector rotation is evident with defensives and domestic consumption plays outperforming export-oriented IT and pharma. Key risk this month remains elevated VIX at 25.52 signaling near-term volatility; opportunity lies in quality midcaps trading at reasonable valuations post the Q4 correction.
5-year revenue CAGR, EBITDA margin trajectory, ROE/ROCE vs sector peers, promoter holding, debt coverage ratios, and competitive moat assessment.
Weekly & daily chart structure, key support/resistance, RSI, MACD signal, ADX trend strength, Bollinger Band squeeze, entry zone, stop-loss, and 3 price targets.
10-parameter AI scoring across 15 screened candidates — earnings quality, promoter conviction, TAM expansion, margin trajectory. Top 3 high-conviction candidates with research thesis. For study purposes only.
This month's basket performance analysis, hypothetical rebalancing scenarios, and forward catalyst calendar for each theme. Illustrative — not a directive to buy or sell.
Conservative, Balanced Growth, and Aggressive Alpha portfolio returns vs benchmark. Position sizing adjustments, sector weight changes, and next-quarter outlook.
Rotating spotlight on one sector each month — supply-demand dynamics, regulatory tailwinds/headwinds, top 5 stocks by conviction, and risk factors.
Aggregated conviction scores, portfolio risk metrics (beta, max drawdown, Sharpe), key monitorables for the quarter, and early-warning indicators to watch.
Unlock the full 8-part report
Get Parts 2–8 plus monthly Multibagger candidates, Basket analysis, Portfolio frameworks, and the full Risk & Conviction Scorecard. New report every month. For educational purposes only.
₹99/month or ₹999/year · Cancel anytime